Screener
Royalty Pharma RPRX Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Royalty Pharma’s reported figures.
Based on the most recent quarter.
The source filing: Royalty Pharma’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 9:02 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001802768-26-000015
FAQ
- What is Royalty Pharma's price / sales?
- Royalty Pharma (RPRX) reported price / sales of 9.8× in Q2 2026.
- How has Royalty Pharma's price / sales changed year-over-year?
- Royalty Pharma's price / sales increased by 48.4% year-over-year, from 6.6× to 9.8×.
- What is the long-term trend for Royalty Pharma's price / sales?
- Over 5 years (2020 to 2025), Royalty Pharma's price / sales has grown at a -7.3% compound annual growth rate (CAGR), from 10.1× to 6.9×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Royalty Pharma's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude